New nonculture-based methods for the diagnosis of invasive candidiasis.
OBJECTIVE
Invasive candidiasis is a severe infectious complication occurring mostly in onco-hematologic and surgical patients. Its conventional diagnosis is insensitive and often late, leading to a delayed treatment and a high mortality. The purpose of this article is to review recent contributions in the nonconventional diagnostic approaches of invasive candidiasis, both for the detection of the epidose and the characterization of the etiologic agent.


RESULTS
Antigen-based tests to detect invasive candidiasis comprise a specific test, mannan, as well as a nonspecific test, beta-D-glucan. Both have a moderate sensitivity and a high specificity, and cannot be recommended alone as a negative screening tool or a positive syndrome driven diagnostic tool. Molecular-based tests still have not reached the stage of rapid, easy to use, standardized tests ideally complementing blood culture at the time of blood sampling. New tests (fluorescence in-situ hybridization or mass spectrometry) significantly reduce the delay of identification of Candida at the species level in positive blood cultures, and should have a positive impact on earlier appropriate antifungal therapy and possibly on outcome.


CONCLUSIONS
Both antigen-based and molecular tests appear as promising new tools to complement and accelerate the conventional diagnosis of invasive candidiasis with an expected significant impact on earlier and more focused treatment and on prognosis.
Bille
Jacques
J
Institute of Microbiology, University Hospital CHUV, Lausanne, Switzerland. Jacques.Bille@chuv.ch
D058365:Candidiasis, Invasive / Q000175:diagnosis* / Q000209:etiology; D016638:Critical Illness; D003955:Diagnostic Tests, Routine / Q000379:methods*; D006801:Humans; D012680:Sensitivity and Specificity